Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate to severe plaque‐type psoriasis
Recent studies have shown that biological drugs approved for treating psoriasis and psoriatic arthritis are not effective in all patients, and that variations in the genome have been associated with different clinical responses or side effects.
Segreteria SIDeMaST, 08 May 2019 04:54
